➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Merck
Boehringer Ingelheim
Harvard Business School
Colorcon

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Chlorpromazine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for chlorpromazine hydrochloride and what is the scope of freedom to operate?

Chlorpromazine hydrochloride is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Hikma, Fosun Pharma, Abraxis Pharm, Dr Reddys, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Upsher Smith Labs, Vangard, West Ward, Zydus, and Parke Davis, and is included in sixty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for chlorpromazine hydrochloride. Fifteen suppliers are listed for this compound.

Recent Clinical Trials for chlorpromazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityPhase 1/Phase 2
Centre Hospitalier St AnnePhase 3
Hôpital CochinPhase 3

See all chlorpromazine hydrochloride clinical trials

Pharmacology for chlorpromazine hydrochloride
Drug ClassPhenothiazine

US Patents and Regulatory Information for chlorpromazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma SONAZINE chlorpromazine hydrochloride SYRUP;ORAL 083040-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis PROMAPAR chlorpromazine hydrochloride TABLET;ORAL 084423-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 084114-001 Approved Prior to Jan 1, 1982 AB RX No Yes   Start Trial   Start Trial   Start Trial
Wockhardt CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride CONCENTRATE;ORAL 087032-001 Jul 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
West Ward CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 087783-001 Sep 16, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Merck
Boehringer Ingelheim
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.